Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Age-Related Macular Degeneration”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Not applicableStudy completedNCT00331331
What this trial is testing

The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease

Who this might be right for
UveitisVasculitisOcular Inflammatory Disease
National Eye Institute (NEI) 147
Very early researchActive Not RecruitingNCT07021027
What this trial is testing

Eggs and Age-related Macular Degeneration (EggsAMD) Study.

Who this might be right for
Intermediate Age-Related Macular Degeneration
Kathryn Starr 19
Testing effectiveness (Phase 2)Study completedNCT00615693
What this trial is testing

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

Who this might be right for
UveitisPosterior UveitisPanuveitis
Novartis 13
Not applicableStudy completedNCT03438669
What this trial is testing

Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients

Who this might be right for
Macular Degeneration
Dr. med. Katja Hatz 53
Not applicableStudy completedNCT05698316
What this trial is testing

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

Who this might be right for
Age Related Macular DegenerationIntermediate AMDAtrophy+1 more
Association for Innovation and Biomedical Research on Light and Image 1,000
Not applicableStudy completedNCT04187157
What this trial is testing

Association Between Light Spectrum and Survival After Cataract Surgery

Who this might be right for
CataractAge-related CataractCircadian Rhythm Disorders+2 more
University of Pittsburgh 10,192
Not applicableStudy completedNCT03079570
What this trial is testing

Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels

Who this might be right for
Age FactorAge-related Macular Degeneration
ORA, Inc. 9
Early research (Phase 1)Study completedNCT02848313
What this trial is testing

An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Stealth BioTherapeutics Inc. 40
Not applicableWithdrawnNCT01336907
What this trial is testing

Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Notal Vision Ltd.
Testing effectiveness (Phase 2)Study completedNCT00447954
What this trial is testing

An Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration

Who this might be right for
Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage
Neurotech Pharmaceuticals 53
Not applicableActive Not RecruitingNCT05300724
What this trial is testing

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Genentech, Inc. 400
Large-scale testing (Phase 3)Looking for participantsNCT07189169
What this trial is testing

QA108 Phase III Study in Subjects With Intermediate AMD

Who this might be right for
Intermediate Age-Related Macular Degeneration
Smilebiotek Zhuhai Limited 400
Post-approval studies (Phase 4)Study completedNCT01988662
What this trial is testing

UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)

Who this might be right for
Neovacular Age-related Macular Degeneration
Novartis Pharmaceuticals 205
Not applicableStudy completedNCT05904444
What this trial is testing

The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies

Who this might be right for
Macular DegenerationLow VisionStargardt Disease
Aier Eye Hospital, Guangzhou 29
Not applicableUnknownNCT02126904
What this trial is testing

Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept

Who this might be right for
The Injection Burden
Yokohama City University Medical Center 200
Not applicableStudy completedNCT03958461
What this trial is testing

Connection Between Periodontitis and Exudative Age-related Macular Degeneration

Who this might be right for
Periodontitis
University of Helsinki 13
Not applicableLooking for participantsNCT06355830
What this trial is testing

Intermediate Age-related Macular Degeneration - Multimodal Analysis and Longitudinal Study

Who this might be right for
Age-Related Macular Degeneration
Universidade Nova de Lisboa 150
Large-scale testing (Phase 3)Study completedNCT04450329
What this trial is testing

Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Samsung Bioepis Co., Ltd. 449
Testing effectiveness (Phase 2)Looking for participantsNCT04735263
What this trial is testing

Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD

Who this might be right for
Age-related Macular Degeneration
Massachusetts Eye and Ear Infirmary 21
Not applicableStudy completedNCT05988827
What this trial is testing

Effect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Early or Intermediate AMD

Who this might be right for
Macular Degeneration, Age RelatedCataract
Elsan 42
Load More Results